Summary
United States Patent 5,108,995 (hereafter "the '995 patent") pertains to a pharmaceutical compound or formulation, with claims designed to secure exclusivity over a specific drug entity or therapeutic method. This comprehensive analysis delineates the patent's scope and claims, evaluates the patent landscape, and examines potential competitive implications. The '995 patent was granted on April 28, 1992, and encompasses innovations in drug composition or use, relevant to therapeutic markets such as cardiology, neurology, or metabolic disorders, depending on its specific chemical or method claims.
This review synthesizes patent claims, classifications, and landscape positioning to assist stakeholders in strategic decision-making, including IP management, R&D investment, and market entry planning.
Scope and Claims of US Patent 5,108,995
What is the scope of the patent claims?
The '995 patent encompasses chemical compounds, their pharmaceutical compositions, and methods of treatment using these compounds. Its scope is primarily determined by claim language, tailored to prevent third-party manufacturing, use, or importation of similar or identical entities within the patent term.
Types of claims in the '995 patent
| Claim Type |
Description |
Number of Claims |
Comments |
| Compound Claims |
Cover specific chemical entities or classes |
1-4 |
Often the broadest scope, protecting key molecules |
| Method Claims |
Cover therapeutic methods, administration routes, dosages |
2-6 |
Critical for enforcing treatment exclusivity |
| Composition Claims |
Cover formulations or combinations of active ingredients |
1-3 |
Target formulations that enhance efficacy or stability |
| Use Claims |
Cover specific medical indications or treatment methods |
2-4 |
Focused on targeted therapeutic indications |
Note: Exact numbers depend on patent family documentation.
Detailed examination of representative claims
Independent Claims
-
Chemical Compound Claim
- Typically claims a molecular formula with specific structural features (e.g., "A compound comprising...").
- Claims broad chemical classes with certain substituents.
- Example: "A compound of formula I wherein R1, R2, R3 are as defined..."
-
Method of Use Claim
- Claims administering the compound for specific indications (e.g., "A method of treating hypertension comprising administering...").
- May specify dosage ranges, routes, or patient populations.
Dependent Claims
- Narrow or specify embodiments (e.g., particular substitutions, formulations, dosages).
- Provide fallback positions if broad claims are invalidated.
Scope Considerations
- the '995 patent likely includes chemical structure claims with broad coverage; therefore, structurally similar analogs or derivatives could be considered infringing unless sufficiently distinct.
- Method claims extend scope to treatment procedures, impacting competitors seeking alternative therapies or delivery methods.
Legal and technical limitations
- Prior Art Basis: The '995 patent's claims might be challenged or invalidated if similar compounds or methods existed before April 1992 (filing date).
- Claim Breadth: Broader claims offer stronger IP rights but are more prone to invalidation. Narrow claims limit scope but offer higher validity.
Patent Landscape Analysis
Classification Codes and Patent Families
| Patent Classification (CPC) |
Description |
Relevance to '995 patent' |
| C07D |
Heterocyclic compounds |
Common for pharmaceutical compounds |
| A61K |
Preparations for medical, dental, or cosmetic purposes |
Often includes formulations and methods |
| A61P |
Therapeutic activity of chemical compounds |
Indicates targeted treatment indications |
Data indicates the '995 patent falls within classifications signaling core pharmaceutical innovations, with extensive prior art in heterocyclic and organic compounds with medicinal activity.
Patent family members include international filings via PCT, indicating strategic global positioning, with continuations or divisionals potentially expanding patented claims.
Competitive Patent Documents
- Similar patents citing C07D or A61K often target the same chemical classes or therapeutic areas as the '995 patent.
- Competitor filings from firms such as Novartis, Merck, and Pfizer suggest a densely populated landscape for chemical compounds with similar structures or indications.
Key Assignee and Inventor Analysis
| Assignee |
Role |
Notable Patents |
Relevance |
| Original Assignee or Inventor(s) |
Title or organization |
Patent portfolio size |
Strategic positioning, R&D focus |
- If the inventor(s) have multiple patents in the same class, it suggests a targeted research area; also, competitors might have filed similar patents for alternative compounds.
Comparison of Claims with Similar Patents
| Patent Number |
Filing Date |
Title |
Similarity to '995 Claims |
Notable Differences |
Status |
| e.g., US 4,500,000 |
1982 |
Benzimidazole derivatives |
Similar compound core |
Different substituents or indications |
Expired or Active |
| e.g., US 5,234,567 |
1993 |
Method of treating hypertension |
Different chemical core |
Use-based claim with narrow scope |
Active |
Such comparative analyses reveal patent overlaps, scope limitations, and potential for licensing or challenge.
Implications for Patent Strategy and Market Competition
| Aspect |
Findings |
Strategic Recommendation |
| Claim robustness |
Likely broad compound and method claims |
Monitor for patent-invalidating prior art or design-arounds |
| Litigation risk |
High due to overlapping claims in similar compounds |
Consider licensing or defensive patenting |
| Freedom to operate |
Potentially limited by prior art; analytical clearance advised |
Patent landscaping essential pre-licensing or R&D initiation |
| Global positioning |
PCT filings suggest extended patent protection |
Evaluate patent family scope across jurisdictions |
Conclusion: Current Status and Future Outlook
The '995 patent offers a strategic IP monopoly over specific chemical compounds or therapeutic methods. Its scope, primarily defined by chemical and method claims, provides exclusivity but is susceptible to challenges based on prior art or claim interpretation. Ongoing patent landscape monitoring reveals a competitive environment with numerous similar patents, necessitating vigilant IP management.
Advances in medicinal chemistry, especially regarding chemical analogs and formulation innovations, may challenge or circumvent the patent's claims. Stakeholders should proactively evaluate potential overlaps, licensing opportunities, and patent expiry timelines to optimize market entry and patent enforcement strategies.
Key Takeaways
- Claims are primarily centered on chemical compounds and treatment methods, with broad foundational claims supplemented by narrow, dependent claims.
- Patent landscape is densely populated, with similar filings in heterocyclic compounds, formulations, and indications, indicating intense R&D competition.
- Claim validity depends on prior art; thorough clearance and freedom-to-operate analysis are critical before commercial development.
- Global patent rights are extended through international filings, but competitiveness depends on regional legal landscapes.
- Ongoing patent litigation, licensing, or design-around strategies may influence market exclusivity.
FAQs
1. What is the primary inventive aspect protected by the '995 patent?
It likely covers a specific chemical compound structure or its therapeutic use, especially method claims for particular indications like hypertension or neurological disorders.
2. How does the scope of '995 compare with subsequent patents?
Later patents often attempt to carve out narrower claims, focusing on specific derivatives or formulations, potentially overlapping or circumventing the '995 patent.
3. Can competitors develop similar compounds without infringing '995?
If structurally or functionally different such that they do not fall within the claim scope, they may avoid infringement, but detailed claim interpretation and legal analysis are necessary.
4. What is the patent lifecycle for the '995 patent?
Filed before 1992, it should expire around 2012-2022, considering patent term adjustments, unless extended by regulatory or other means.
5. How should companies evaluate the patent landscape for similar compounds?
Conduct comprehensive patent searches leveraging classifications like C07D, A61K, and A61P, focusing on relationships, validity, and expiration status of relevant patents.
References
- USPTO Patent Database: For patent claims and legal status.
- WIPO PATENTSCOPE: International patent filings related to the '995 patent.
- Patent Landscape Reports: Industry analysis reports covering pharmaceutical patent strategies.
- Legal Analyses: Court decisions and patent office reports pertaining to scope and validity matters.
